Name: Name:Ethyl 2-methylthiazole-4-carboxylate
Brand: AABLOCKS
SKU: AA003Q25
Rating: 90 (10 reviews)

Catalog No.: AA003Q25

6436-59-5 | Ethyl 2-methylthiazole-4-carboxylate

Pack Size： 1g

Purity： 97%

in stock

$9.00 $7.00

Pack Size： 10g

Purity： 97%

in stock

$21.00 $15.00

Pack Size： 25g

Purity： 97%

in stock

$50.00 $35.00

Pack Size： 100g

Purity： 97%

in stock

$188.00 $132.00

Quantity

- +

Add to Card

Order Now

bulk Quotation Request

Technical Information

Catalog Number: AA003Q25

Chemical Name: Ethyl 2-methylthiazole-4-carboxylate

CAS Number: 6436-59-5

Molecular Formula: C7H9NO2S

Molecular Weight: 171.2169

MDL Number: MFCD00156148

SMILES: CCOC(=O)c1csc(n1)C

NSC Number: 159893

Properties

BP: 242.1°C at 760 mmHg

Form: Solid

MP: 54-56°C

Storage: Keep in dry area;Room Temperature;

Complexity: 151

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 11

Hydrogen Bond Acceptor Count: 4

Hydrogen Bond Donor Count: 0

Isotope Atom Count: 0

Rotatable Bond Count: 3

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

XLogP3: 1.9

Upstream Synthesis Route

6436-59-5

35272-15-2

[1]EuropeanJournalofMedicinalChemistry,2017,vol.126,p.776-788

[2]Patent:US2007/105891,2007,A1,.Locationinpatent:Page/Pagecolumn10

[3]Patent:US2006/160857,2006,A1,.Locationinpatent:Page/Pagecolumn31

[4]ChemistryofHeterocyclicCompounds,2011,vol.47,#6,p.703-709

[5]Patent:WO2004/58702,2004,A2,.Locationinpatent:Page29;23

6436-59-5

31825-95-3

[1]BioorganicandMedicinalChemistryLetters,2002,vol.12,#8,p.1203-1208

[2]Patent:WO2011/106414,2011,A1,.Locationinpatent:Page/Pagecolumn83

[3]JournaloftheChemicalSociety,1946,p.91

[4]JournalofOrganicChemistry,2009,vol.74,#15,p.5750-5753

[5]JournaloftheAmericanChemicalSociety,2011,vol.133,#15,p.5900-5904

6436-59-5

14527-43-6

73956-17-9

[1]JournalofOrganicChemistry,2009,vol.74,#15,p.5750-5753

70-23-5

62-55-5

6436-59-5

[1]JournalofOrganicChemistry,1997,vol.62,#12,p.3804-3805

[2]OrganicLetters,2008,vol.10,#8,p.1565-1568

[3]JournalofOrganicChemistry,2001,vol.66,#19,p.6410-6424

[4]AngewandteChemie-InternationalEdition,2008,vol.47,#46,p.8950-8953

[5]Patent:US2010/249404,2010,A1,.Locationinpatent:Page/Pagecolumn11

[6]AdvancedSynthesisandCatalysis,2014,vol.356,#16,p.3370-3376

[7]TetrahedronLetters,2016,vol.57,#8,p.920-923

[8]EuropeanJournalofMedicinalChemistry,2016,vol.123,p.718-726

[9]TetrahedronLetters,1997,vol.38,#12,p.2061-2064

[10]ChemistryofHeterocyclicCompounds,2011,vol.47,#6,p.703-709

[11]JournalofOrganicChemistry,2004,vol.69,#26,p.9269-9284

[12]Proceedings-IndianAcademyofSciences,SectionA,1945,#22,p.362,376

[13]JournaloftheChemicalSociety,1946,p.91

[14]BioorganicandMedicinalChemistryLetters,2005,vol.15,#9,p.2243-2247

[15]Patent:WO2004/58702,2004,A2,.Locationinpatent:Page29;23

[16]Patent:WO2004/58763,2004,A1,.Locationinpatent:Page38-39

[17]Patent:EP1445249,2004,A1,.Locationinpatent:Page139

[18]Patent:EP1612204,2006,A1,.Locationinpatent:Page/Pagecolumn47

[19]OrganicLetters,2012,vol.14,#24,p.6354-6357

6436-57-3

6436-59-5

[1]TetrahedronLetters,1997,vol.38,#3,p.331-334

[2]JournaloftheChemicalSociety.Perkintransactions1,1966,vol.12,p.1061-1065

Downstream Synthesis Route

6436-59-5

76632-23-0

[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2005/77932,2005,A2Locationinpatent:Page/Pagecolumn169-170

[2]Jung,Jae-Chul;Kache,Rajashaker;Vines,KimberlyK.;Zheng,Yan-Song;Bijoy,Panicker;Valluri,Muralikrishna;Avery,MitchellA.[JournalofOrganicChemistry,2004,vol.69,#26,p.9269-9284]

[3]Nicolaou;Rhoades,Derek;Wang,Yanping;Bai,Ruoli;Hamel,Ernest;Aujay,Monette;Sandoval,Joseph;Gavrilyuk,Julia[JournaloftheAmericanChemicalSociety,2017,vol.139,#21,p.7318-7334]

[4]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2013/149362,2013,A1Locationinpatent:Page/Pagecolumn50

[5]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2013/289238,2013,A1Locationinpatent:Page/Pagecolumn

[6]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO;UNIVERSITYOFMONTREAL-WO2013/163279,2013,A1Locationinpatent:Paragraph00129

[7]Litzinger,ElizabethA.;Martasek,Pavel;Roman,LindaJ.;Silverman,RichardB.[BioorganicandMedicinalChemistry,2006,vol.14,#9,p.3185-3198]

[8]Bagley,MarkC.;Dale,JamesW.;Xiong,Xin;Bower,Justin[OrganicLetters,2003,vol.5,#23,p.4421-4424]

[9]Bagley,MarkC.;Dale,JamesW.;Jenkins,RobertL.;Bower,Justin[ChemicalCommunications,2004,#1,p.102-103]

[10]CurrentPatentAssignee:ASTRAZENECAPLC-US6479527,2002,B1

[11]CurrentPatentAssignee:ASTRAZENECAPLC-EP1056451,2002,B1

[12]Zubarovskii,V.M.;Moskaleva,R.N.[JournalofgeneralchemistryoftheUSSR,1962,vol.32,p.560-564][ZhurnalObshcheiKhimii,1961,vol.32,p.570-575]

[13]Ciufolini,MarcoA.;Shen,YongChun[JournalofOrganicChemistry,1997,vol.62,#12,p.3804-3805]

6436-59-5

78502-71-3

[1]BioorganicandMedicinalChemistry,2001,vol.9,p.1-6

[2]Patent:WO2010/20556,2010,A1.Locationinpatent:Page/Pagecolumn156

[3]Patent:US2006/122256,2006,A1.Locationinpatent:Page/Pagecolumn21

[4]Patent:US2004/266856,2004,A1.Locationinpatent:Page/Pagecolumn19

[5]Patent:US2020/123117,2020,A1.Locationinpatent:Paragraph1108;1109

[6]LiebigsAnnalenderChemie,1981,p.623-632

[7]Bioorganicandmedicinalchemistryletters,2002,vol.12,p.2443-2446

[8]Patent:US6162808,2000,A

[9]Patent:EP1612204,2006,A1.Locationinpatent:Page/Pagecolumn47

[10]Patent:US2012/184521,2012,A1.Locationinpatent:Page/Pagecolumn23

6436-59-5

78502-71-3

78502-72-4

78502-73-5

[1]LiebigsAnnalenderChemie,1981,p.623-632

6436-59-5

101767-28-6

[1]Cowden;Sullivan;Brown[AustralianJournalofChemistry,1985,vol.38,#8,p.1257-1261]

[2]CurrentPatentAssignee:ASTELLASPHARMAINC.-WO2013/50424,2013,A1Locationinpatent:Page/Pagecolumn112-113;138-139

[3]Hoveyda,HamidR.;Fraser,GraemeL.;Roy,Marie-Odile;Dutheuil,Guillaume;Batt,Frédéric;ElBousmaqui,Mohamed;Korac,Julien;Lenoir,François;Lapin,Alexey;Noël,Sophie;Blanc,Sébastien[JournalofMedicinalChemistry,2015,vol.58,#7,p.3060-3082]

[4]CurrentPatentAssignee:TENAYATHERAPEUTICSINC-WO2021/127643,2021,A1Locationinpatent:Paragraph00502-00503